Sienna Cancer Diagnostics Limited
0
1
+A$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Feb 21Expected
Q2 2017
Q4 2017
Q2 2019
Q4 2019
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
-0.01
Financials
-508.98%Profit Margin
Unprofitable756,150.5Revenue
-3.85MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Sienna Cancer Diagnostics Limited, a medical technology company, identifies, develops, and commercializes cancer-related in-vitro diagnostic tests for use in pathology laboratories worldwide. The company offers SCD-A7, an anti-human telomerase reverse transcriptase antibody for the detection of the biomarker for cancer. It also provides SIEN-NET technology, a sample preparation platform to enhance the performance of liquid biopsy diagnostic assays. The company has a research collaboration agreement with Minomic International Ltd to develop a proprietary test for the early detection of pancreatic cancer. The company was formerly known as Sienna Capital Ltd and changed its name to Sienna Cancer Diagnostics Limited in 2006. Sienna Cancer Diagnostics Limited was founded in 2002 and is headquartered in Scoresby, Australia.
Show More
CEO
Mr. Carl S. Stubbings
Country
Australia
ISIN
AU000000SDX1
Listings
0 Comments
Share your thoughts
FAQs
What is Sienna Cancer Diagnostics Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Sienna Cancer Diagnostics Limited stocks are traded under the ticker SDX.AU.
What were Sienna Cancer Diagnostics Limited earnings last quarter?▼
SDX.AU earnings for the last quarter are -0.01 AUD per share, whereas the estimation was 0 AUD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is Sienna Cancer Diagnostics Limited revenue for the last year?▼
Sienna Cancer Diagnostics Limited revenue for the last year amounts to 756,150.5 AUD.
What is Sienna Cancer Diagnostics Limited net income for the last year?▼
SDX.AU net income for the last year is -3.85M AUD.
In which sector is Sienna Cancer Diagnostics Limited located?▼
Sienna Cancer Diagnostics Limited operates in the Health & Wellness sector.
When did Sienna Cancer Diagnostics Limited complete a stock split?▼
Sienna Cancer Diagnostics Limited has not had any recent stock splits.